课题基金 / 基金详情

项目摘要

项目成果

RAFFIT HASSAN的其他基金

相似基金

相关文献

中文摘要
翻译
医疗TGMB有一个强大的临床计划,用于治疗晚期乳腺癌患者。 标准治疗失败的胸部和胃肠道癌症患者。胸科小组正在进行 针对非小细胞肺癌、小细胞肺癌 恶性间皮瘤和胸腺癌。这些措施包括使用新的治疗方法, NCI的科学家我们团队的一个主要重点是开发针对 肿瘤抗原间皮素在许多癌症中高度表达。我们正在使用 免疫毒素-LMB-100,抗体药物偶联物- BAY 94-9343,钍-227标记 抗体-螯合剂缀合物-BAY 2287411和靶向CAR-T细胞的间皮素来治疗这些疾病。 癌的此外,我们正在使用免疫治疗剂进行临床试验,包括 免疫检查点抑制剂用于治疗标准治疗失败的胸部癌症患者 治疗。TGMB还在进行治疗胃肠道癌症的研究, 特别强调肝癌和胰腺癌。TGMB内部的调查人员已经 建立了一个强大的计划,治疗肝癌患者,包括使用 免疫治疗剂单独使用或与放射治疗或局部消融联合使用 肝癌的治疗方法胃肠道小组也在进行临床试验, 治疗胰腺癌的新药物。
英文摘要
The medical TGMB has a robust clinical program for treatment of patients with advanced thoracic and GI cancers who have failed standard therapies. The thoracic team is conducting innovative studies for patients with non-small cell lung cancer, small cell lung cancer, malignant mesothelioma and thymic cancers. These include use of novel treatments developed by scientists at the NCI. A major focus of our team is the development of drugs targeting the tumor antigen, mesothelin that is highly expressed in many cancers. We are using an immunotoxin -LMB-100, an antibody drug conjugate- BAY 94-9343, thorium-227 labeled antibody-chelator conjugate-BAY 2287411 and mesothelin targeting CAR-T cells to treat these cancers. In addition, we are conducting clinical trials using immunotherapy agents including immune checkpoint inhibitors to treat patients with thoracic cancers who have failed standard treatments. The TGMB is also conducting studies for treatment of gastrointestinal cancers with a special emphasis on liver and pancreatic cancer. Investigators within the TGMB have established a robust program for treatment of patients with liver cancer including use of immunotherapy agents either alone or in combination with radiation therapy or locally ablative therapies for liver cancer. The gastrointestinal group is also conducting clinical trials of novel agents for treatment of pancreatic cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Clinical evaluation of an anti-mesothelin immunotoxin
Immunotherapy for Malignant Mesothelioma and Lung Cancer
  • 批准号:
    10702415
  • 项目类别:
  • 资助金额:
    $201.88万
  • 财政年份:
    --
  • 负责人:
    RAFFIT HASSAN
  • 依托单位:
Immunotherapy for Malignant Mesothelioma, Lung Cancer and Thymic Malignancies
Immunotherapy for Malignant Mesothelioma
海外基金